Aisling Capital is a New York-based investment firm focused on healthcare and life sciences, investing in biopharmaceuticals, medical devices, and healthcare services. Founded in 2000, it has raised over $1.8 billion across five funds.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Aisling Capital is an investment firm founded in 2000 and based in New York, NY. The firm focuses on investing in companies that develop and commercialize healthcare products, services, and technologies. Aisling Capital has raised over $1.8 billion in committed capital across five funds and employs a team with extensive experience in the healthcare industry. Their investment strategy is driven by a fundamental assessment of scientific, regulatory, financial, and commercial risks, engaging in seed and venture financing for development-stage companies, small-cap publicly traded equities, structured debt, royalty deals, and large-cap leveraged buyouts.
Aisling Capital invests in both private and public companies within the life sciences sector. Their investment strategy includes seed and venture financing for development-stage companies, small-cap publicly traded equities, structured debt, royalty deals, and large-cap leveraged buyouts of profitable companies.
Aisling Capital adds value to its portfolio companies through its extensive industry experience, strategic guidance, and access to a broad network within the healthcare sector.
Aisling Capital focuses on companies within the life sciences sector, including biotechnology, medical devices, and healthcare services. They invest in both private and public companies at various stages, from seed to growth equity.
Founders can reach out directly through the contact information provided on Aisling Capital's website. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
Aisling Capital's extensive experience in the healthcare sector and its significant capital commitment set it apart. The firm has a long history of supporting healthcare innovation and offers strategic guidance to its portfolio companies.
The firm primarily invests in North America, focusing on companies that are developing healthcare solutions that address unmet medical needs.
Aisling Capital provides strategic guidance and access to a broad network within the healthcare sector, helping portfolio companies navigate challenges and capitalize on opportunities.
Aisling Capital invests across a range of stages, with check sizes varying based on the company's development stage and specific needs. They engage in seed financing as well as larger growth equity investments.
Organizations that do similar work to Aisling Capital.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorAccelerating life sciences innovation in Massachusetts.
InvestorTransforming healthcare through strategic investments.
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Superscout Pro
Is this page right?Reviewed · How the research works